Clinical Trial Update: Memantine Plus Es-citalopram in Elderly Depressed Patients With Cognitive Impairment [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 clinical trial evaluated memantine in combination with escitalopram in elderly patients with mild cognitive impairment and major depressive di…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Cognitive Impairment
• Major Depressive Disorder

Drugs mentioned

• Lexapro (escitalopram)
• Namenda (memantine)

Snippet

Sponsor: New York State Psychiatric Institute | Conditions: Mild Cognitive Impairment, Major Depressive Disorder | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2014-10-24